Carnitine and sports medicine: Use or abuse?

Annals of the New York Academy of Sciences

Volumn 1033, Issue , 2004, Pages 67-78

  Brass, Eric P ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Carnitine; Exercise; Homeostasis; Metabolism; Skeletal muscle; Supplementation

Indexed keywords

CARNITINE;

AEROBIC CAPACITY; BIOENERGY; CONFERENCE PAPER; EXERCISE; HOMEOSTASIS; HUMAN; METABOLIC REGULATION; MUSCLE FUNCTION; MUSCLE METABOLISM; PHYSICAL PERFORMANCE; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; SPORTS MEDICINE; SUPPLEMENTATION;

EID: 10644243305     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1320.006     Document Type: Conference Paper

References (53)

1. BREMER, J. 1983. Carnitine - metabolism and functions. Physiol. Rev. 63: 1420-1480.
2. RASMUSSEN, U.F. & H.N. RASMUSSEN. 2000. Human skeletal muscle mitochondrial capacity. Acta Physiol. Scand. 168: 473-480.
3. UZIEL, G., B. GARAVAGLIA & S. DI DONATO. 1988. Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11: 720-724.
4. KERNER, J. & C. HOPPEL. 1998. Genetic disorders of carnitine metabolism and their nutritional management. Annu. Rev. Nutr. 18: 179-206.
5. GOA, K.L. & R.N. BROGDEN. 1987. L-Carnitine: a preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs 34: 1-24.
6. HIATT, W.R., J.G. REGENSTEINER, E.E. WOLFEL et al. 1989. Carnitine and acylcarnitine metabolism during exercise in humans: dependence on skeletal muscle metabolic state. J. Clin. Invest. 84: 1167-1173.
7. OPALKA, J.R., F.N. GELLERICH & S. ZIERZ. 2001. Age and sex dependency of carnitine concentration in human serum and skeletal muscle. Clin. Chem. 47: 2150-2153.
8. ARENAS, J., J.R. RICOY, A.R. ENCINAS et al. 1991. Carnitine in muscle, serum, and urine of nonprofessional athletes: effects of physical exercise, training, and L-carnitine administration. Muscle Nerve 14: 598-604.
9. BRASS, E.P. & W.R. HIATT. 1998. The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. J. Am. Coll. Nutr. 17: 207-215.
10. BRASS, E.P. 2000. Supplemental carnitine and exercise. Am. J. Clin. Nutr. 72: 618S-623S.
11. LEBORGNE, F. & J. DEMARQUOY. 2003. Carnitine et performance physique. Sci. Sports 18: 125-133.
12. WALTER, J.H. 1996. L-Carnitine. Arch. Dis. Child. 74: 475-478.
13. MILLER, B. & S. AHMAD. 2003. A review of the impact of L-carnitine therapy on patient functionality in maintenance hemodialysis. Am. I. Kidney Dis. 41: S44-S48.
14. BREVETTI, G., M. CHIARIELLO, G. FERULANO et al. 1988. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation 77: 767-773.
15. BRASS, E.P. 1995. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin. Ther. 17: 176-185; discussion, p. 175.
16. HARPER, P., C.E. ELWIN & G. CEDERBLAD, 1988. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. Eur. J. Clin. Pharmacol. 35: 69-75.
17. SAHAJWALLA, C.G., E.D. HELTON, E.D. PURICH et al. 1995. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J. Pharm. Sci. 84: 627-633.
18. ENGEL, A.G., C.J. REBOUCHE, D.M. WILSON et al. 1981. Primary systemic carnitine deficiency: II. Renal handling of carnitine. Neurology 31: 819-825.
19. TAMAI, I., R. OHASHI, J. NEZU et al. 1988. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273: 20378-20382.
20. WANG, Y., J. YE, V. GANAPATHY & N. LONGO. 1999. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc. Natl. Acad. Sci. USA 96: 2356-2360.
21. TANG, N.L., V. GANAPATHY, X. WU et al. 1999. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum. Mol. Genet. 8: 655-660.
22. REBOUCHE, C.J. & A.G. ENGEL. 1982. Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency. In Vitro 18: 495-500.
23. SARTORELLI, L., M. CIMAN & N. SILIPRANDI. 1985. Carnitine transport in rat heart slices: I. The action of thiol reagents on the acetylcarnitine/ carnitine exchange. Ital. J. Biochem. 34: 275-281.
24. SILIPRANDI, N., F. DI LISA, A. PIVETTA et al. 1987. Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia. Z. Kardiol. 76: 34-40.
25. RUFF, L.J., L.G. MILLER & E.P. BRASS. 1991. Effect of exogenous carnitine on carnitine homeostasis in the rat. Biochim. Biophy. Acta 1073: 543-549.
26. BERARDI, S., B. STIEGER, B. HAGENBUCH et al. 2000. Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles. Eur. J. Biochem. 267: 1985-1994.
27. BRASS, E.P., C.L. HOPPEL & W.R. HIATT. 1994. Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans. Clin. Pharmacol. Ther. 55: 681-692.
28. VUKOVICH, M.D., D.L. COSTILL & W.J. FINK. 1994. Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise. Med. Sci. Sports Exer. 26: 1122-1129.
29. BARNETT, C., D.L. COSTILL, M.D. VUKOVICH et al. 1994. Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cycling. Int. J. Sport Nutr. 4: 280-288.
30. HUERTAS, R., Y. CAMPOS, E. DIAZ et al. 1992. Respiratory chain enzymes in muscle of endurance athletes: effect of L-carnitine. Biochem. Biophys. Res. Commun. 188: 102-107.
31. BACURAU, R.F., F. NAVARRO, R.A. BASSIT et al. 2003. Does exercise training interfere with the effects of L-carnitine supplementation? Nutrition 19: 337-341.
32. WOLFE, R.R. 1998. Fat metabolism in exercise. Adv. Exp. Med. Biol. 441: 147-156.
33. SAHLIN, K. 1990. Muscle carnitine metabolism during incremental dynamic exercise in humans. Acta Physiol. Scand. 138: 259-262.
34. FRIOLET, R., H. HOPPELER & S. KRAHENBUHL. 1994. Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J. Clin. Invest. 94: 1490-1495.
35. MCGARRY, J.D., S.E. MILLS, C.S. LONG & D.W. FOSTER. 1983. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues: demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem. J. 214: 21-28.
36. ZHU, H., J. SHI, Y. DE VRIES et al. 1997. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I. Arch. Biochem. Biophys. 347: 53-61.
37. CARLIN, J.I., R.C. HARRIS, G. CEDERBLAD et al. 1990. Association between muscle acetyl-CoA and acetylcarnitine levels in the exercising horse. J. Appl. Physiol. 69: 42-45.
38. PUTMAN, C.T., L.L. SPRIET, E. HULTMAN et al. 1995. Skeletal muscle pyruvate dehydrogenase activity during acetate infusion in humans. Am. J. Physiol. 268: E1007-E1017.
39. BERTHON, P., M. VAN DER VEER, C. DENIS & D. FREYSSENET. 1997. L-Carnitine stimulation of mitochondrial oxidative phosphorylation rate in isolated rat skeletal muscle mitochondria. Comp. Biochem. Physiol. A Comp. Physiol. 117: 141-145.
40. DI DONATO, S., D. PELUCCHETTI, M. RIMOLDI et al. 1984. Systemic carnitine deficiency: clinical, biochemical, and morphological cure with L-carnitine. Neurology 34: 157-162.
41. TREEM, W.R., C.A. STANLEY, D.N. FINEGOLD et al. 1988. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N. Engl. J. Med. 319: 1331-1336.
42. SHAPIRA, Y., B. GLICK, S. HAREL et al. 1993. Infantile idiopathic myopathic carnitine deficiency: treatment with L-carnitine. Pediatr. Neurol. 9: 35-38.
43. BRASS, E.P. 2002. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol. Rev. 54: 589-598.
44. BEAUMONT, K., R. WEBSTER, I. GARDNER & K. DACK. 2003. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr. Drug Metab. 4: 461-485.
45. HOLME, E., J. GRETER, C.E. JACOBSON et al. 1989. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2: 469-473.
46. HOLME, E., U. JODAL, S. LINSTEDT & I. NORDIN. 1992. Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children. Scand. J. Clin. Lab. Invest. 52: 361-372.
47. BRASS, E.P., M.D. MAYER, D.J. MULFORD et al. 2003. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Clin. Pharmacol. Ther. 73: 338-347.
48. MOLE, P.A., L.B. OSCAI & J.O. HOLLOSZY. 1971. Adaptation of muscle to exercise: increase in levels of palmityl CoA synthetase, carnitine palmitoyltransferase, and palmitoyl CoA dehydrogenase, and in the capacity to oxidize fatty acids. J. Clin. Invest. 50: 2323-2330.
49. SIMI, B., M.H. MAYET, B. SEMPORE & R.J. FAVIER. 1990. Large variations in skeletal muscle carnitine level fail to modify energy metabolism in exercising rats. Comp. Biochem. Physiol. A97: 543-549.
50. GOROSTIAGA, E.M., C.A. MAURER & J.P. ECLACHE. 1989. Decrease in respiratory quotient during exercise following L-carnitine supplementation. Int. J. Sports Med. 10: 169-174.
51. SILIPRANDI, N., F. DI LISA, G. PIERALISI et al. 1990. Metabolic changes induced by maximal exercise in human subjects following L-carnitine administration. Biochim. Biophys. Acta 1034: 17-21.
52. SOOP, M., O. BJORKMAN, G. CEDERBLAD et al. 1988. Influence of carnitine supplementation on muscle substrate and carnitine metabolism during exercise. J. Appl. Physiol. 64: 2394-2399.
53. WASSERMAN, K. & B.J. WHIPP. 1975. Exercise physiology in health and disease. Am. Rev. Respir. Dis. 112: 219-249.